Clinical Trials on Troubles du métabolisme du phosphore

Total 260 results

Sihuan Pharmaceutical Holdings Group Ltd.

Completed

A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

Duodenal Ulcer，DU

China
Sihuan Pharmaceutical Holdings Group Ltd.

Unknown

A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

Duodenal Ulcer，DU
Carmel Medical Center

Unknown

The Relationship Between Ca Intake , Blood Level of Ca, PTH, TSH, Vitamin D, and Urine Ca, P and Cardiac Calcium Scoring (TSHPTHCA)

Disorders of Phosphorus and Calcium Metabolism
National Institute of Dental and Craniofacial Research...

Completed

Studying Phosphorus Metabolism

Phosphorus Metabolism

United States
Grand Life Science (Liaoning) Co., Ltd.
The First Hospital of Jilin University

Recruiting

To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder

Hyperphosphatemia

China
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
RWTH Aachen University

Terminated

Velphoro and Impact on the Oral Cavity and Gut Microbiome (MicrobiomEisen)

Hyperphosphatemia

Germany
MetroHealth Medical Center

Completed

Phosphorus Improvement Pilot Study

Hyperphosphatemia
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
Kyowa Kirin Korea Co., Ltd.

Recruiting

Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients

Hyperphosphatemia

Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Bayer

Completed

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD)

Hyperphosphatemia

Japan
Bayer

Completed

Bioequivalence Study of BAY77-1931 Granule

Hyperphosphatemia

Japan
Washington University School of Medicine

Completed

The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

Hyperphosphatemia

United States
Kyowa Kirin Co., Ltd.

Completed

Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

Hyperphosphatemia

Japan
Ardelyx

Completed

A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis

Hyperphosphatemia

United States
Kaiser Permanente
Keryx Biopharmaceuticals

Completed

Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients

Hyperphosphatemia

United States
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Shire

Completed

Long-term Effect of Lanthanum Carbonate on Bone

Hyperphosphatemia

United States, Germany, United Kingdom
Bayer

Completed

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan (FOSRENOL-HD)

Hyperphosphatemia

Japan
Vifor Fresenius Medical Care Renal Pharma

Completed

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) (VERIFIE)

Hyperphosphatemia

Spain, Netherlands, Germany, Italy, France, Greece, United Kingdom
Jiujiang No.1 People's Hospital

Unknown

Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia (NAHPH)

Hyperphosphatemia

China
Rijnstate Hospital

Completed

FGF-23 Suppressibility by Calcitonin

Hypophosphatemia

Netherlands
Shiraz University of Medical Sciences

Completed

The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients

Hyperphosphatemia

Iran, Islamic Republic of
Bayer

Completed

BAY 77-1931 Long-term Extension From Phase II Study

Hyperphosphatemia

Japan
Shanghai Jiao Tong University School of Medicine
Baxter Healthcare Corporation

Unknown

The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients

Hyperphosphatemia

China
Romanian Society of Nephrology

Withdrawn

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate

Hyperphosphatemia | Haemodialyzed Patients

Romania
Fresenius Medical Care Deutschland GmbH
Siro Clinpharm Germany GmbH

Completed

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) (Steering)

ESRD | Hyperphosphataemia

United Kingdom, Spain, Denmark, Germany
Fresenius Medical Care North America
Renal Research Institute

Completed

Phosphate Kinetic Modeling 2 (PKM2)

ESRD | Hyperphosphatemia

United States
Bayer

Completed

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Hyperphosphatemia | Dialysis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
University Hospital, Geneva

Completed

Newborn Phosphocalcic Metabolism After Intravenous Iron Administration During Pregnancy

Iron Induced Hypophosphatemia

Switzerland
Hospital Universitari de Bellvitge
Vifor Pharma

Active, not recruiting

mHealth for Phosphorus Management in CKD. (PHOSFO_OK)

Dialysis Related Complication

Spain
Chugai Pharma Taiwan

Completed

Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

Hemodialysis | Hyperphosphatemia | Cardiovascular Events
Chen Jing
Shanghai Tongji Hospital, Tongji University School of Medicine; Huadong Hospital

Completed

Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients

Hyperphosphatemia | Maintenance Hemodialysis

China
Daiichi Sankyo, Inc.

Completed

DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis

Hyperphosphatemia

United States
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

Peritoneal Dialysis | Hyperphosphatemia

Japan
Fresenius Medical Care North America

Completed

Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers

Hyperphosphatemia

United States
AstraZeneca

Completed

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

Zollinger-Ellison Syndrome | Reflux Esophagitis (RE) | Gastric Ulcer (GU) | Duodenal Ulcer (DU) | Anastomotic Ulcer (AU) | Non-erosive Reflux Esophagitis Disease (NERD)

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia Patients on Hemodialysis

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis Patients With Hyperphosphatemia

Japan
Medical University of Warsaw
Polish Academy of Sciences; University of Warsaw

Completed

The Effect of Bicarbonate Profiling in Dialysis Fluid on Phosphate Removal During Hemodialysis and Blood pH

Phosphorus Metabolism Disorders | Acid-Base Balance Disorder

Poland
Taipei Medical University WanFang Hospital

Unknown

The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient

Malnutrition | Hyperphosphatemia

Taiwan
University of Tartu

Recruiting

Validation of the GIDS and Description of Phosphate Disorders (GUTPHOS)

Hypophosphatemia | Organ Dysfunction Scores

Estonia
University College Cork
Cork University Hospital; Irish Nutrition & Dietetic Institute

Completed

Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices (DIP HD)

Hyperphosphatemia | Dietary Modification | Renal Dialysis

Ireland
Linda W. Moore
The Methodist Hospital Research Institute

Completed

Dietary Phosphate and Serum Phosphorus

Phosphorus Metabolism Disorders
University Hospital, Brest

Completed

Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU (PORPOISE-REA)

Infection | Hypophosphatemia

France

Clinical Trials on Troubles du métabolisme du phosphore

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations